Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukocyte Disorders | 1 | 2023 | 12 | 0.900 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.750 |
Why?
|
Neutropenia | 1 | 2023 | 885 | 0.610 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.590 |
Why?
|
Venous Thromboembolism | 4 | 2024 | 1866 | 0.560 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1405 | 0.440 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.400 |
Why?
|
Thrombosis | 2 | 2022 | 2942 | 0.380 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.320 |
Why?
|
Sepsis | 1 | 2022 | 2585 | 0.310 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5821 | 0.230 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3358 | 0.220 |
Why?
|
Dioxygenases | 1 | 2024 | 345 | 0.200 |
Why?
|
Leukocytosis | 1 | 2023 | 251 | 0.200 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5440 | 0.200 |
Why?
|
Administration, Cutaneous | 1 | 2023 | 713 | 0.190 |
Why?
|
Hematology | 1 | 2024 | 243 | 0.180 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2023 | 237 | 0.180 |
Why?
|
Mutation | 2 | 2024 | 30053 | 0.180 |
Why?
|
Inpatients | 2 | 2023 | 2548 | 0.170 |
Why?
|
Mitochondrial Diseases | 2 | 2014 | 343 | 0.170 |
Why?
|
Intensive Care Units | 3 | 2022 | 3744 | 0.170 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 301 | 0.160 |
Why?
|
Mentors | 1 | 2024 | 661 | 0.160 |
Why?
|
DNA, Mitochondrial | 2 | 2014 | 865 | 0.150 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2014 | 49 | 0.140 |
Why?
|
Leukemia, Experimental | 1 | 2017 | 225 | 0.140 |
Why?
|
Heparin | 2 | 2021 | 1634 | 0.140 |
Why?
|
Lipid Metabolism, Inborn Errors | 2 | 2014 | 123 | 0.130 |
Why?
|
Heart Failure | 1 | 2019 | 11671 | 0.120 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2017 | 682 | 0.110 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2014 | 138 | 0.110 |
Why?
|
Muscular Diseases | 2 | 2014 | 553 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2024 | 4514 | 0.100 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1303 | 0.100 |
Why?
|
Chromatin | 1 | 2023 | 2961 | 0.100 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2023 | 3600 | 0.090 |
Why?
|
Critical Illness | 1 | 2022 | 2723 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 22173 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2020 | 422 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2019 | 1853 | 0.070 |
Why?
|
Humans | 18 | 2024 | 761596 | 0.070 |
Why?
|
DNA Damage | 1 | 2017 | 2449 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2024 | 9610 | 0.070 |
Why?
|
Fibrinogen | 2 | 2020 | 888 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2020 | 2567 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9327 | 0.070 |
Why?
|
Anticoagulants | 4 | 2023 | 4812 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2023 | 80647 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3271 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8656 | 0.060 |
Why?
|
Risk Factors | 2 | 2024 | 74213 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12130 | 0.060 |
Why?
|
Aged | 5 | 2024 | 169310 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Adult | 5 | 2024 | 221210 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5305 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 23996 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2013 | 1860 | 0.050 |
Why?
|
Antigens, CD19 | 1 | 2023 | 424 | 0.040 |
Why?
|
Prothrombin Time | 1 | 2020 | 117 | 0.040 |
Why?
|
Middle Aged | 4 | 2024 | 220921 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2020 | 204 | 0.040 |
Why?
|
Sequence Deletion | 2 | 2014 | 1494 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2020 | 411 | 0.040 |
Why?
|
Taxoids | 1 | 2002 | 668 | 0.040 |
Why?
|
Female | 7 | 2024 | 392705 | 0.040 |
Why?
|
Male | 5 | 2024 | 360846 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 858 | 0.040 |
Why?
|
Enoxaparin | 1 | 2020 | 391 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39969 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2023 | 64685 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 598 | 0.040 |
Why?
|
Hydrazones | 1 | 2017 | 103 | 0.040 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 350 | 0.040 |
Why?
|
Ligands | 1 | 2023 | 3272 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1336 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2024 | 1117 | 0.030 |
Why?
|
Cytarabine | 1 | 2017 | 698 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58984 | 0.030 |
Why?
|
Paclitaxel | 1 | 2002 | 1732 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1084 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2547 | 0.030 |
Why?
|
Thromboembolism | 1 | 2020 | 995 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1899 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 573 | 0.030 |
Why?
|
Immunotherapy, Adoptive | 1 | 2023 | 1469 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1913 | 0.030 |
Why?
|
Lysine | 1 | 2017 | 993 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3492 | 0.030 |
Why?
|
Anemia, Sideroblastic | 1 | 2013 | 109 | 0.030 |
Why?
|
Pilot Projects | 1 | 2024 | 8633 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41495 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4281 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5791 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2580 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5971 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12794 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10194 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4111 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6345 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10090 | 0.010 |
Why?
|
Estramustine | 1 | 2002 | 35 | 0.010 |
Why?
|
Fibroblasts | 1 | 2013 | 4142 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15843 | 0.010 |
Why?
|
Survival | 1 | 2002 | 161 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14417 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21355 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 11742 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16990 | 0.010 |
Why?
|
Child, Preschool | 2 | 2014 | 42232 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3397 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22174 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12973 | 0.010 |
Why?
|
Microtubules | 1 | 2002 | 1074 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11530 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2002 | 21019 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13642 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4853 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36193 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2002 | 4915 | 0.010 |
Why?
|
Child | 1 | 2014 | 80158 | 0.000 |
Why?
|
Animals | 1 | 2017 | 168475 | 0.000 |
Why?
|
Concepts
(128)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(102)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_